Forget crash diets and other fads: we spoke to experts for advice on safe, scientific approaches to meeting your weight goals ...

Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...

The experimental obesity medicine is one of two that could offer alternatives to weight-loss injections within the next year ...

Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...

A man who says he got 'Ozempic penis' from the weight loss drug Wegovy has opened up on how his sex life has been going ...

A once-daily oral pill helped people with obesity lower their weight by an average of 12% after 72 weeks, according to manufacturer Eli Lilly. Dr. Sue Decotiis, a weight-loss doctor in New York City, ...